Cytori Therapeutics, Inc. Reports Third Quarter 2015 Business and Financial Results

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today announced its third quarter financial results and provided updates on its corporate activity and clinical development.

Third quarter 2015 net income allocable to common stockholders was $1.5 million, or a net loss of $5.8 million and $0.04 per share when excluding a non-cash charge of $7.3 million related to the change in fair value of warrant liabilities.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC